| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/02/2012 | WO2012014896A1 Method for forming tissue pieces for tissue array, and device for forming tissue pieces for tissue array |
| 02/02/2012 | WO2012014890A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 02/02/2012 | WO2012014795A1 Novel ret fused body detection method |
| 02/02/2012 | WO2012014694A1 Method for synthesis of feces-derived nucleic acid |
| 02/02/2012 | WO2012014208A2 Methods and systems for assessing clonality of cell cultures |
| 02/02/2012 | WO2012014190A2 Compositions and methods for prognosis of mesothelioma |
| 02/02/2012 | WO2012014156A2 Diagnosis of bacterial meningitis based on the measure of ros production in a sample of cerebrospinal fluid |
| 02/02/2012 | WO2012014116A1 Probes and primers for detection of dengue |
| 02/02/2012 | WO2012013937A1 Sensor coasting layer, device and method |
| 02/02/2012 | WO2012013936A1 Corticogenesis of human pluripotent cells |
| 02/02/2012 | WO2012013931A1 Methods for diagnosing cancer |
| 02/02/2012 | WO2012013734A1 Control nucleic acids for multiple parameters |
| 02/02/2012 | WO2012013733A1 Generic sample preparation |
| 02/02/2012 | WO2012013732A1 Generic pcr |
| 02/02/2012 | WO2012013731A1 Qualitative and quantitative detection of microbial nucleic acids |
| 02/02/2012 | WO2012013621A1 Methods and uses relating to the identification of compound associated with bacterial infection |
| 02/02/2012 | WO2012013614A1 Method for the identification of catechol o-methyltransferase modulators |
| 02/02/2012 | WO2012013127A1 Nucleotide and/or oligonucleotide and preparation process thereof |
| 02/02/2012 | WO2011156913A3 An optical pathogen detection system and quality control materials for use in same |
| 02/02/2012 | WO2011156467A3 Methods of detecting residual amounts of polymers used in the purification of biomolecules |
| 02/02/2012 | WO2011153472A3 C-cbl mutations and uses thereof |
| 02/02/2012 | WO2011152566A3 Composition for inducing proliferation or accumulation of regulatory t cells |
| 02/02/2012 | WO2011149354A8 Mirnas involved in the blood brain barrier function |
| 02/02/2012 | WO2011142861A3 Isothermal amplification of nucleic acid using a mixture of randomized primers and specific primers |
| 02/02/2012 | WO2011130595A3 Sirtuin activators and activation assays |
| 02/02/2012 | WO2011127040A3 High throughput screening of ion channels |
| 02/02/2012 | WO2011116088A3 Compositions and methods for the detection of genomic features |
| 02/02/2012 | WO2011109806A9 Biomarkers for the identification, monitoring, and treatment of non-small cell lung cancer (nsclc) |
| 02/02/2012 | WO2011106536A3 Methods of diagnosing infectious disease pathogens and their drug sensitivity |
| 02/02/2012 | WO2011106401A3 Methods and compositions relating to multiciliate cell differentiation |
| 02/02/2012 | WO2011106322A3 Biomarkers for acute ischemic stroke |
| 02/02/2012 | WO2011102680A3 Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway |
| 02/02/2012 | WO2011094335A3 Microrna signatures predicting responsiveness to anti-her2 therapy |
| 02/02/2012 | WO2011093675A3 Biological method and system for selecting diagnostic marker for subtype of lung cancer directly from blood, and marker for diagnosis of lung cancer selected with the system |
| 02/02/2012 | WO2011084047A3 Identification of molecular markers associated with fatty acid composition in plants |
| 02/02/2012 | US20120030834 Methods and compositions for root knot nematode control |
| 02/02/2012 | US20120030781 Lrrk2 polynucleotides and transgenic animals |
| 02/02/2012 | US20120030780 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 02/02/2012 | US20120030777 Methods for testing for caloric restriction (cr) mimetics |
| 02/02/2012 | US20120030776 Novel gene disruptions, compositions and methods relating thereto |
| 02/02/2012 | US20120029416 Porous electroactive hydrogels and uses thereof |
| 02/02/2012 | US20120029332 Method of Continuously Measuring Substrate Concentration |
| 02/02/2012 | US20120029180 A h+-gated ion channel |
| 02/02/2012 | US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 02/02/2012 | US20120029062 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 02/02/2012 | US20120029061 Rna sequence-specific mediators of rna interference |
| 02/02/2012 | US20120029056 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome |
| 02/02/2012 | US20120029003 Galectin-3 and statin therapy |
| 02/02/2012 | US20120028915 6"-amino-6"-deoxygalactosylceramides |
| 02/02/2012 | US20120028903 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 02/02/2012 | US20120028900 Method of producing factor viii proteins by recombinant methods |
| 02/02/2012 | US20120028895 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control |
| 02/02/2012 | US20120028889 Integrase cofactor |
| 02/02/2012 | US20120028880 Vegfr-1/nrp-1 targeting peptides |
| 02/02/2012 | US20120028879 Highly sensitive detection method for highly virulent oral cavity bacteria |
| 02/02/2012 | US20120028838 Quantification of Gene Expression |
| 02/02/2012 | US20120028837 Rapid screen for reproductive toxicants |
| 02/02/2012 | US20120028833 MiR-25-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) |
| 02/02/2012 | US20120028832 MiR-182-, miR-191, miR-199a-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) |
| 02/02/2012 | US20120028831 MiR-29-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) |
| 02/02/2012 | US20120028829 Anti-hedgehog antibodies |
| 02/02/2012 | US20120028827 Method for determining a risk, for a subject, of suffering from atopic dermatitis or severity of atopic dermatitis for a subject suffering from atopic dermatitis and method for using a single-nucleotide polymorphism rs12313273 as a biomarker for determining the development or severity of atopic dermatitis |
| 02/02/2012 | US20120028825 Galectin-1 (gal1) as a biomarker for differential diagnosis of osteosarcoma and chondrosarcoma |
| 02/02/2012 | US20120028822 Methods, flow cells and systems for single cell analysis |
| 02/02/2012 | US20120028821 Programming and reprogramming of cells |
| 02/02/2012 | US20120028818 Micro fluidic structures |
| 02/02/2012 | US20120028817 Methods and Kits for Genome-Wide Methylation of GpC Sites and Genome-Wide Determination of Chromatin Structure |
| 02/02/2012 | US20120028815 Nucleic acid sequencing using microsphere arrays |
| 02/02/2012 | US20120028812 Method for producing second-generation library |
| 02/02/2012 | US20120028312 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 02/02/2012 | US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 02/02/2012 | US20120028297 Environmental sampling articles and methods |
| 02/02/2012 | US20120028296 Fecal sample collection and processing apparatus and method |
| 02/02/2012 | US20120028295 Synergistic composition useful as microbiological growth medium for rapid screening of phosphate accumulating microorganisms |
| 02/02/2012 | US20120028294 Home test kit for detecting fecal blood |
| 02/02/2012 | US20120028293 Mixing device and mixing method for mixing small amounts of liquid |
| 02/02/2012 | US20120028292 Methods for diagnosing kidney damage associated with heart failure |
| 02/02/2012 | US20120028291 Charged-balanced imaging agents |
| 02/02/2012 | US20120028290 Compositions and Methods for Labeling and Imaging Phospholipids |
| 02/02/2012 | US20120028289 Method of identifying endogenous fluorescent biological markers for monitoring cells |
| 02/02/2012 | US20120028288 Method for Measuring Cell Motility and System Therefor |
| 02/02/2012 | US20120028287 Crystal Structure of Aldehyde Dehydrogenase and Methods of Use Thereof |
| 02/02/2012 | US20120028286 Method for evaluating the breakdown of proteins, polypeptides and peptides |
| 02/02/2012 | US20120028285 Clickable cross-linker |
| 02/02/2012 | US20120028284 Trapping compounds and method for identifying reactive metabolites |
| 02/02/2012 | US20120028283 Analyte Sensors Having Temperature Independent Membranes |
| 02/02/2012 | US20120028282 Biosensor system and method for measuring concentration of analyte |
| 02/02/2012 | US20120028278 Cell lines expressing guanylate cyclase-c and methods of using them |
| 02/02/2012 | US20120028276 Methods for diagnosis of myelodysplastic syndromes (mds) |
| 02/02/2012 | US20120028275 Biomimetic membrane for cell expansion |
| 02/02/2012 | US20120028270 Metal-enhanced bioluminescence: an approach for monitoring biological bioluminescent processes |
| 02/02/2012 | US20120028266 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites |
| 02/02/2012 | US20120028264 Method for using gene expression to determine prognosis of prostate cancer |
| 02/02/2012 | US20120028263 Method for screening a salty taste modulating substance |
| 02/02/2012 | US20120028262 Genes and polypeptides relating to human pancreatic cancers |
| 02/02/2012 | US20120028261 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention |
| 02/02/2012 | US20120028260 Rad9 as a diagnostic, prognostic and therapeutic tool for prostate cancer |
| 02/02/2012 | US20120028259 Compositions for improving gene amplification |
| 02/02/2012 | US20120028258 Receptor gene screening for detecting or diagnosing cancer |
| 02/02/2012 | US20120028257 Modified luciola cruciata luciferase gene and protein |